Enhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cells

References

• Alakhov VY, Moskaleva EY, Batrakova EV, Kabanov AV. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjug Chem 1996; 7(2)209–16
   PubMed Web of Science ®Google Scholar
• Allen TM. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Deliv Rev 1994; 13(3)285–309
   Web of Science ®Google Scholar
• Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, Kim DD, Kim JS, Yoo BK, Choi HG, et al. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 2009; 377(1–2)1–8
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kabanov AV. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008; 130(2)98–106
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Lee S, Li S, Venne A, Alakhov VY, Kabanov AV. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res 1999; 16(9)1373–9
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Li S, Alakhov VY, Elmquist WF, Miller DW, Kabanov AV. Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. Pharm Res 2003; 20(10)1581–90
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Li S, Elmquist WF, Miller DW, Alakhov VY, Kabanov AV. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. Br J Cancer 2001; 85(12)1987–97
   PubMed Web of Science ®Google Scholar
• Broxterman HJ, Lankelma J, Hoekman K. Resistance to cytotoxic and anti-angiogenic agents: Similarities and differences. Drug Resist Update 2003; 6(3)111–27
   PubMedGoogle Scholar
• Chen H, Bamberger U, Heckel A, Guo X, Cheng Y. BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport. Cancer Res 1993; 53(9)1974–7
   PubMedGoogle Scholar
• Johnsson M, Silvander M, Karlsson G, Edwards K. Effect of PEO–PPO–PEO triblock copolymers on structure and stability of phosphatidylcholine liposomes. Langmuir 1999; 15(19)6314–25
   Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. Pluronic® block copolymer as novel polymer therapeutics for drug and gene delivery. J Control Release 2002a; 82: 189–212
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev 2002b; 54(5)759–79
   PubMed Web of Science ®Google Scholar
• Kang DI, Kang HK, Gwak HS, Han HK, Lim SJ. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells. Drug delivery 2009; 16(5)261–7
   PubMed Web of Science ®Google Scholar
• Kostarelos K, Tadros TF, Luckham PF. Physical conjugation of (tri-) block copolymers to liposomes toward the construction of sterically stabilized vesicle systems. Langmuir 1999; 15(2)369–76
   Web of Science ®Google Scholar
• Lo YL. Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem Pharmacol 2000; 60(9)1381–90
   PubMedGoogle Scholar
• Mamot C, Drummond DC, Hong K, Kirpotin DB, Park JW. Liposome-based approaches to overcome anticancer drug resistance. Drug Resist Update 2003; 6(5)271–9
   PubMed Web of Science ®Google Scholar
• Mayer LD, Shabbits JA. The role for liposomal drug delivery in molecular and pharmacological strategies to overcome multidrug resistance. Cancer Metast Rev 2001; 20(1–2)87–93
   PubMedGoogle Scholar
• Minko T, Batrakova EV, Li S, Li Y, Pakunlu RI, Alakhov VY, Kabanov AV. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. J Control Release 2005; 105(3)269–78
   PubMedGoogle Scholar
• Minko T, Stefanov A, Pozharov V. Selected contribution: Lung hypoxia: Antioxidant and antiapoptotic effects of liposomal alpha-tocopherol. J Appl Physiol 2002; 93(4)1550–60; discussion 1549
   PubMedGoogle Scholar
• Moghimi SM, Porter CJH, Illum L, Davis SS. The effect of poloxamer-407 on liposome stability and targeting to bone marrow: Comparison with polystyrene microspheres. Int J Pharm 1991; 68: 121–6
   Web of Science ®Google Scholar
• Mu CF, Balakrishnan P, Cui FD, Yin YM, Lee YB, Choi HG, Yong CS, Chung SJ, Shim CK, Kim DD. The effects of mixed MPEG–PLA/Pluronic® copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials 2010; 31(8)2371–9
   PubMed Web of Science ®Google Scholar
• Pani A, Batetta B, Putzolu M, Sanna Fm, Spano O. MDR1, cholesterol esterification and cell growth: A comparative study in normal and multidrug-resistant KB cell lines. Cell Mol Life Sci 2000; 57(7)1094–102
   PubMedGoogle Scholar
• Renes J, de Vries EGE, Jansen PLM, Muller M. The (patho)physiological functions of the MRP family. Drug Resist Update 2000; 3(5)289–302
   PubMed Web of Science ®Google Scholar
• Song CK, Jung SH, Kim DD, Jeong KS, Shin BC, Seong H. Disaccharide-modified liposomes and their in vitro intracellular uptake. Int J Pharm 2009; 380(1–2)161–9
   PubMedGoogle Scholar
• Su F, Hu X, Jia W, Gong C, Song E, Hamar P. Glutathion S transferase π indicates chemotherapy resistance in breast cancer. J Surg Res 2003; 113(1)102–8
   PubMedGoogle Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005; 4: 145–60
   PubMed Web of Science ®Google Scholar
• Venne A, Li S, Mandeville R, Kabanov AV, Alakhov VY. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res 1996; 56(16)3626–9
   PubMed Web of Science ®Google Scholar
• Warren L, Jardillier JC, Malarska A, Akeli MG. Increased accumulation of drugs in multidrug-resistant cells induced by liposomes. Cancer Res 1992; 52(11)3241–5
   PubMedGoogle Scholar